3/20/2024 | 29309099 | RACECADOTRIL D.O MFG 08/2023 D.O EXP 07/2028 FOR TEST TRIAL AND CLINICAL ANALYSIS | SYMED LABS LIMITED | 0.21 | KG | 510.965541 | India | KPAF |
3/6/2024 | 29339990 | CARVEDILOL (FOR CLINICAL TRIAL EXAMINATION TEST OR ANALYSIS) D.O MFG 01/2024 D.O EXP 12/2026 | TRANSWORLD MIDDLEEAST FZE | 2 | KG | 608.098137 | India | KPAF |
3/4/2024 | 29333990 | ESOMEPRAZOLE PELLETS 22.5% FOR CLINICAL TRIALS AND TESTING PURPOSES (DRAP FORM 6 ATTACHED) | LEE PHARMA LIMITED | 5 | KG | 160.308133 | India | KPAF |
3/4/2024 | 29333990 | OMEPRAZOLE PELLETS 8.5% FOR CLINICAL TRIALS AND TESTING PURPOSES (DRAP FORM 6 ATTACHED) | LEE PHARMA LIMITED | 5 | KG | 97.71408 | India | KPAF |
3/4/2024 | 29333990 | OMEPRAZOLE PELLETS 22.5% FOR CLINICAL TRIALS AND TESTING PURPOSES (DRAP FORM 6 ATTACHED) | LEE PHARMA LIMITED | 5 | KG | 142.497312 | India | KPAF |
3/4/2024 | 29333990 | ESOMEPRAZOLE PELLETS 8.5% FOR CLINICAL TRIALS AND TESTING PURPOSES (DRAP FORM 6 ATTACHED) | LEE PHARMA LIMITED | 5 | KG | 111.963453 | India | KPAF |
2/13/2024 | 29359090 | CLINICAL TRIAL PURPOSE
LEVOSULPRIDE | KIMIA BIOSCIENCES LIMITED | 1.5 | KG | 145.63 | India | KPAF |
1/27/2024 | 29349990 | PHARMACEUTICAL RAW MATERIAL FOR CLINICAL TRIAL EXAMINATION TEST OR ANALYSIS: RELUGOLIX (INCLUDING 100 MG WS AND 10 MG IMPURITY RO - 03) BATCH NO. RO23001B MFG DT: 04/2023 RETEST DT: 03/2025 | LEE PHARMA LIMITED | 1.5 | KG | 10903.63 | India | KPAF |
1/18/2024 | 29321900 | CLINICAL TRIAL PURPOSE EMPAGLIFLOZIN | CENTURY PHARMACEUTICALS LIMITED | 0.05 | KG | 459.86 | India | KPAF |
1/8/2024 | 29333990 | OMEPRAZOLE LYOPHILIZED (34% TO 38% W/W) (FOR CLINICAL TRIAL EXAMINATION TEST OR ANALYSIS) D.O MFG 09/203 D.O EXP 08/2026 DRAP FORM 6 ATTACHED | TRANSWORLD MIDDLE EAST FZE | 1 | KG | 278.9 | India | KPAF |